Minimal Residual Disease-based Treatment is Adequate for Relapse-prone Childhood Acute Lymphoblastic Leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALL-BFM 2000 trial.

Details

Language :

English

ISSN :

03008630

Volume :

226

Issue :

6/7

Database :

Complementary Index

Journal :

Klinische Pädiatrie

Publication Type :

Academic Journal

Accession number :

99727238

Full Text :

https://doi.org/10.1055/s-0034-1387795